Urinary Retention — The Effect of Modified Supine Position on Urinary Elimination After Percutaneous Coronary Intervention
Citation(s)
Abdollahi AA, Mehranfard S, Behnampour N, Kordnejad AM Effect of Positioning and Early Ambulation on Coronary Angiography Complications: a Randomized Clinical Trial. J Caring Sci. 2015 Jun 1;4(2):125-34. doi: 10.15171/jcs.2015.013. eCollection 2015 Jun.
Alagöl B Idrar retansiyonu: Üroloji 3. Baski; Ed.: Osman Inci. Ankara: Günes Kitabevi 2006; 1-5.
Bakan G Perkütan koroner girisimlerde kanita dayali bakim uygulamalari. Turkish Journal of Cardiovascular Nursing. June 2016; 7(sup 1):26-34.
Liu Y, Zhang Y, Wu Y, Elliott M A Modified Supine Position Facilitates Bladder Function in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Clinical Trial. J Cardiovasc Nurs. 2018 Mar/Apr;33(2):152-159. doi: 10.1097/JCN.0000000000000436.
Liu YS, Wei S, Elliott M The effects of a catheter clamping protocol on bladder function in neurosurgical patients: a controlled trial. Int J Nurs Pract. 2015 Feb;21(1):29-36. doi: 10.1111/ijn.12209. Epub 2013 Nov 13.
Mohammady M, Atoof F, Sari AA, Zolfaghari M Bed rest duration after sheath removal following percutaneous coronary interventions: a systematic review and meta-analysis. J Clin Nurs. 2014 Jun;23(11-12):1476-85. doi: 10.1111/jocn.12313. Epub 2013 Sep 13.
Niknam Sarabi H, Farsi Z, Butler S, Pishgooie AH Comparison of the effectiveness of position change for patients with pain and vascular complications after transfemoral coronary angiography: a randomized clinical trial. BMC Cardiovasc Disord. 2021 Feb 25;21(1):114. doi: 10.1186/s12872-021-01922-w.
Onat A TEKHARF 2017 Tip dünyasinin kronik hastalilarina öncülük. Erisim Adresi: https://file.tkd.org.tr/PDFs/TEKHARF-2017.pdf. Erisim Tarihi: 25.06.2022.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
